Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis

Atherosclerosis is the leading cause of cardiovascular disease among adults. The incidence of atherosclerosis increases significantly with age, which indicates the possible influence of aging mechanisms on the development of the disease, including changes in epigenetic factors caused by pathological...

Full description

Saved in:
Bibliographic Details
Main Authors: R. N. Mustafin, E. A. Galieva
Format: Article
Language:Russian
Published: SINAPS LLC 2024-04-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/1747
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850040321499463680
author R. N. Mustafin
E. A. Galieva
author_facet R. N. Mustafin
E. A. Galieva
author_sort R. N. Mustafin
collection DOAJ
description Atherosclerosis is the leading cause of cardiovascular disease among adults. The incidence of atherosclerosis increases significantly with age, which indicates the possible influence of aging mechanisms on the development of the disease, including changes in epigenetic factors caused by pathological activation of transposable elements. Triggers of atherosclerosis are also viral infections, which promote the expression of retroelements that stimulate the interferon response with the development of chronic inflammation. Activated retroelements also alter the regulation of immune system genes and epigenetic factors, including the pathological production of microRNAs and long non-coding RNAs. A promising direction for atherosclerosis treatment is the epigenetic impact on the expression of specific genes involved in the pathogenesis of atherosclerosis using small interfering RNAs. In this regard, the drugs inclisiran and olpasiran have undergone clinical trials and have shown their effectiveness. Therefore, it is important to search for new molecular targets in this direction, which can serve as transposons, which are sources of non-coding RNAs. Changes in the activity of retroelements during aging have a global regulatory effect on the functioning of the entire genome, contributing to the development of age-associated pathology. An analysis of the scientific literature made it possible to identify 29 microRNAs derived from retroelements, changes in the expression of which have been identified both during aging and atherosclerosis. These microRNAs can be used as tools for prolonging life and treating cardiovascular pathology. The results obtained also indicate that retroelements pathologically activated during aging cause the development of atherosclerosis.
format Article
id doaj-art-32bb06586bba405d89cbd4cd373d5f4f
institution DOAJ
issn 2226-6704
2411-6564
language Russian
publishDate 2024-04-01
publisher SINAPS LLC
record_format Article
series Архивъ внутренней медицины
spelling doaj-art-32bb06586bba405d89cbd4cd373d5f4f2025-08-20T02:56:08ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642024-04-01142859510.20514/2226-6704-2024-14-2-85-95983Role of MicroRNAs and Retroelements in the Pathogenesis of AtherosclerosisR. N. Mustafin0E. A. Galieva1Bashkir State Medical UniversityUfa University of Science and TechnologyAtherosclerosis is the leading cause of cardiovascular disease among adults. The incidence of atherosclerosis increases significantly with age, which indicates the possible influence of aging mechanisms on the development of the disease, including changes in epigenetic factors caused by pathological activation of transposable elements. Triggers of atherosclerosis are also viral infections, which promote the expression of retroelements that stimulate the interferon response with the development of chronic inflammation. Activated retroelements also alter the regulation of immune system genes and epigenetic factors, including the pathological production of microRNAs and long non-coding RNAs. A promising direction for atherosclerosis treatment is the epigenetic impact on the expression of specific genes involved in the pathogenesis of atherosclerosis using small interfering RNAs. In this regard, the drugs inclisiran and olpasiran have undergone clinical trials and have shown their effectiveness. Therefore, it is important to search for new molecular targets in this direction, which can serve as transposons, which are sources of non-coding RNAs. Changes in the activity of retroelements during aging have a global regulatory effect on the functioning of the entire genome, contributing to the development of age-associated pathology. An analysis of the scientific literature made it possible to identify 29 microRNAs derived from retroelements, changes in the expression of which have been identified both during aging and atherosclerosis. These microRNAs can be used as tools for prolonging life and treating cardiovascular pathology. The results obtained also indicate that retroelements pathologically activated during aging cause the development of atherosclerosis.https://www.medarhive.ru/jour/article/view/1747atherosclerosismicrornasretroelementstargeted therapy
spellingShingle R. N. Mustafin
E. A. Galieva
Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
Архивъ внутренней медицины
atherosclerosis
micrornas
retroelements
targeted therapy
title Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
title_full Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
title_fullStr Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
title_full_unstemmed Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
title_short Role of MicroRNAs and Retroelements in the Pathogenesis of Atherosclerosis
title_sort role of micrornas and retroelements in the pathogenesis of atherosclerosis
topic atherosclerosis
micrornas
retroelements
targeted therapy
url https://www.medarhive.ru/jour/article/view/1747
work_keys_str_mv AT rnmustafin roleofmicrornasandretroelementsinthepathogenesisofatherosclerosis
AT eagalieva roleofmicrornasandretroelementsinthepathogenesisofatherosclerosis